Skip to Main Content
<< Back | Return to Main COMAR Search Page

7 records match your request.

FileAbstract
10.28.12.00.htm 10.28.12.00. Title 10 MARYLAND DEPARTMENT OF HEALTH Subtitle 28 BOARD OF EXAMINERS IN OPTOMETRY Chapter 12 Therapeutic Pharmaceutical Agents Authority: Health Occupations Article, §11-101, 11-205, 11-302―11-309, 11-401.1, 11-404, and 11-404.1, Annotated Code of Maryland
10.28.12.01.htm 10.28.12.01. 01 Definitions.. A. In this chapter, the following terms have the meanings indicated.. B. Terms Defined.. 1) "Adverse drug reaction" means a physical or psychological reaction experienced by a patient which:a) Results from the administration of diagnostic or therapeutic pharmaceutical agents;. b) Poses a threat to the health of the patient; and. c) Requires treatment or medical intervention.. 2) "Adverse reaction" means the unintended or unexpected effect of treatme
10.28.12.02.htm 10.28.12.02. 02 Requirements for Certification.. A. Except for an optometrist who qualifies under §B or C of this regulation, the Board shall certify an optometrist licensed to practice in Maryland as qualified to use TPAs if the licensed optometrist submits to the Board evidence satisfactory to the Board that the optometrist:1) Has successfully completed at least 110 hours of Board-approved TPA education before applying for certification to use TPAs;2) Has successfully passe
10.28.12.03.htm 10.28.12.03. 03 Requirements for Renewal of Certification.. A. An optometrist certified by the Board under this chapter shall complete 50 hours of continuing education during the 2 year licensure period in order to renew the optometrist's license.B. An optometrist certified by the Board under this chapter shall complete 30 hours of continuing education in the use and management of TPAs, during the 2-year licensure period.C. The Board shall count the 30 hours of continuing education in TPAs towar
10.28.12.04.htm 10.28.12.04. 04 Standards of Quality for Therapeutically Certified Optometrists and Optometric Care.. A. The therapeutically certified optometrist shall provide clinical therapeutic eye care consistent with published, universally accepted practice or clinical guidelines and standards of care.B. The therapeutically certified optometrist shall adhere to the additional guidelines and standards of care given in §C―T of this regulation.C. The therapeutically certified optometrist shall ensure that:.
10.28.12.05.htm 10.28.12.05. 05 Monitoring of Complaint Investigation.. A. The Board shall review complaints against optometrists relating to ocular therapeutics, management of primary open angle glaucoma, removal of superficial foreign bodies, and other aspects of practice by a therapeutically certified optometrist.B. The Board's procedures for handling complaints are governed by Health Occupations Article, Title 11, Annotated Code of Maryland, COMAR 10.28.04, and State Government Articl
10.28.12.9999.htm 10.28.12.9999. Administrative History Effective date:. Regulations .01―08 adopted as an emergency provision effective May 17, 1996 (23:12 Md. R. 867) adopted permanently effective October 21, 1996 (23:21 Md. R. 1467)Regulation .01B amended effective October 19, 2009 (36:21 Md. R. 1591). Regulations .02 amended as an emergency provision effective December 7, 2001 (28:26 Md. R. 2270) amended permanently effective March 4, 2002 (29:4 Md. R. 417)Regulation .02 amended effective October 19, 2009
<< Back | Return to Main COMAR Search Page